Latest reporting
Xylazine Wound Care Has Been Guessing — Two Baltimore Studies Just Asked the Patients Instead
A 315-person survey found 4 in 10 people who inject drugs in Baltimore have had a xylazine wound. A companion study asked them why — and pointed straight at gaps in clinician training.
Xylazine Scheduling Didn't Shrink the Tranq Crisis. It Created a Worse One.
A new study links state xylazine scheduling to a surge in medetomidine, a more potent, harder-to-detect veterinary sedative now dominating drug supplies from Philadelphia to the Northeast.
Banning Three Named Chemicals Won't Close the Loophole Selling Opioids as Kratom
The DEA scheduled three synthetic kratom chemicals in August, but the real 7-OH threshold is still a proposal. Arizona's own kratom fix died in the legislature in June. The gap is the point.
Through eight lenses
Science
Alpha-2 agonists (xylazine, medetomidine — veterinary sedatives), nitazenes as μ-opioid agonists (synthesized in 1950s, never approved, re-emerging), kratom mitragynine partial μ-agonist + alpha-2, tianeptine atypical antidepressant with opioid activity at high doses.
Biology
Xylazine causes necrotic skin ulcers characteristic + prolonged sedation not reversed by naloxone; nitazenes act like high-potency fentanyl analogs (naloxone-reversible, higher dosing may be needed); kratom has its own withdrawal syndrome; tianeptine "gas station heroin" causing emergency-dept surges.
Psychology
Dependence patterns mirror the parent class but often with gaps in clinical recognition.
Policy
DEA scheduling scramble — xylazine FDA-declared emerging threat, nitazene analogs being scheduled piecemeal, kratom DEA deferred twice, tianeptine state-by-state patchwork.
Trends
Xylazine now in 48 states' supply; medetomidine identified in Chicago-area 2024; kratom retail boom.
The DEA Already Banned Kratom's Cousin Chemical. In Three Days, It Decides How Much of the Original Survives.
Sep 7Xylazine Is Losing Ground in the Drug Supply. What's Replacing It Is Worse, and Naloxone Still Won't Touch Either One.
Sep 5The Feds Are Scheduling Three New Drugs at Once. The Chemists Are Already on a Fourth.
Aug 28
Treatment
Xylazine wound care + opioid co-treatment; nitazene overdose reversal with naloxone; kratom dependence — buprenorphine effective; tianeptine dependence — like opioids.
Harm Reduction
Test strips for xylazine + nitazenes (where available), stay with person during prolonged sedation, don't use alone, high-dose naloxone availability.